Paper27192579
Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch.
MacLeod DT and 21 others. Immunity, 2016. Cited by 123 papers, by iCite.
Cite this record
ConductScience Library. Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch. Papers, record 27192579. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27192579
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| Antibodies, Neutralizing | Major topic |
| B-Lymphocytes | Major topic |
| HIV Antibodies | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Africa South of the Sahara | |
| Antibody Diversity | |
| Biological Evolution | |
| Cell Differentiation | |
| Complementarity Determining Regions | |
| High-Throughput Nucleotide Sequencing | |
| Humans | |
| Immunodominant Epitopes | |
| Lymphocyte Activation | |
| Mannose | |
| env Gene Products, Human Immunodeficiency Virus |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K24 AI100665 | NIAID NIH HHS | United States | K24AI100665 | PubMed and NIH | NIH RePORTER |
| UM1 AI100663 | NIAID NIH HHS | United States | UM1AI100663 | PubMed and NIH | NIH RePORTER |
| R01 AI084817 | NIAID NIH HHS | United States | R01AI084817 | PubMed and NIH | NIH RePORTER |
| R01 GM093939 | NIGMS NIH HHS | United States | R01GM093939 | PubMed and NIH | NIH RePORTER |
| T32 AI007244 | NIAID NIH HHS | United States | T32AI007244 | PubMed and NIH | NIH RePORTER |
| U01 GM110749 | NIGMS NIH HHS | United States | U01GM110749 | PubMed and NIH | NIH RePORTER |
| U19 AI090970 | NIAID NIH HHS | United States | U19AI090970 | PubMed and NIH | NIH RePORTER |
| R56 AI084817 | NIAID NIH HHS | United States | R01AI084817 | PubMed and NIH | NIH RePORTER |
| K99 AI120851 | NIAID NIH HHS | United States | K99AI120851 | PubMed and NIH | NIH RePORTER |
| R56AI084817 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04596098 | Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine. | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 27192575 | HIV Immunology Goes Out On a Limb. | https://conductscience.org/library/papers/27192575 |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11581307 | Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11581307 | PubMed |
| 2 | 11823785 | Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. | Nature | 2002 | https://conductscience.org/library/papers/11823785 | PubMed |
| 3 | 12920303 | Predominant autoantibody production by early human B cell precursors. | Science | 2003 | https://conductscience.org/library/papers/12920303 | PubMed |
| 4 | 1382098 | VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. | J Immunol | 1992 | https://conductscience.org/library/papers/1382098 | PubMed |
| 5 | 15860590 | Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. | Science | 2005 | https://conductscience.org/library/papers/15860590 | PubMed |
| 6 | 16211091 | Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. | J Clin Invest | 2005 | https://conductscience.org/library/papers/16211091 | PubMed |
| 7 | 1710250 | Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype. | J Immunol | 1991 | https://conductscience.org/library/papers/1710250 | PubMed |
| 8 | 17996249 | Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. | J Immunol Methods | 2008 | https://conductscience.org/library/papers/17996249 | PubMed |
| 9 | 18449194 | Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. | Nature | 2008 | https://conductscience.org/library/papers/18449194 | PubMed |
| 10 | 19004942 | Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals. | J Virol | 2009 | https://conductscience.org/library/papers/19004942 | PubMed |
| 11 | 19729618 | Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. | Science | 2009 | https://conductscience.org/library/papers/19729618 | PubMed |
| 12 | 20616233 | Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. | Science | 2010 | https://conductscience.org/library/papers/20616233 | PubMed |
| 13 | 20622876 | Conserved structural elements in the V3 crown of HIV-1 gp120. | Nat Struct Mol Biol | 2010 | https://conductscience.org/library/papers/20622876 | PubMed |
| 14 | 20686044 | Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16. | J Virol | 2010 | https://conductscience.org/library/papers/20686044 | PubMed |
| 15 | 20700449 | A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. | PLoS Pathog | 2010 | https://conductscience.org/library/papers/20700449 | PubMed |
| 16 | 21764753 | Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. | Science | 2011 | https://conductscience.org/library/papers/21764753 | PubMed |
| 17 | 21835983 | Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. | Science | 2011 | https://conductscience.org/library/papers/21835983 | PubMed |
| 18 | 21849977 | Broad neutralization coverage of HIV by multiple highly potent antibodies. | Nature | 2011 | https://conductscience.org/library/papers/21849977 | PubMed |
| 19 | 21998254 | A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. | Science | 2011 | https://conductscience.org/library/papers/21998254 | PubMed |
| 20 | 22333067 | PANDAseq: paired-end assembler for illumina sequences. | BMC Bioinformatics | 2012 | https://conductscience.org/library/papers/22333067 | PubMed |
Cited by107
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42809389 | Deletions in variable region 1 of the HIV envelope accelerate V3-glycan bNAb induction in SHIV-infected rhesus macaques. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42809389 | PubMed |
| 42096521 | Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design. | Science | 2026 | https://conductscience.org/library/papers/42096521 | PubMed |
| 41985438 | Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques. | Immunity | 2026 | https://conductscience.org/library/papers/41985438 | PubMed |
| 41867827 | Early clonal dominance at priming sets the trajectory for broad HIV serum neutralization. | bioRxiv | 2026 | https://conductscience.org/library/papers/41867827 | PubMed |
| 41686912 | Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV V2 apex broadly neutralizing antibody development. | Sci Immunol | 2026 | https://conductscience.org/library/papers/41686912 | PubMed |
| 41634485 | Rapid elicitation of neutralizing Asn332-glycan-independent antibodies to the V3-glycan epitope of HIV-1 Env in nonhuman primates. | Nat Immunol | 2026 | https://conductscience.org/library/papers/41634485 | PubMed |
| 41279569 | Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279569 | PubMed |
| 41278942 | Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design. | bioRxiv | 2025 | https://conductscience.org/library/papers/41278942 | PubMed |
| 40868286 | Glycomics in Human Diseases and Its Emerging Role in Biomarker Discovery. | Biomedicines | 2025 | https://conductscience.org/library/papers/40868286 | PubMed |
| 40838752 | Parallel evolution of the elite neutralizer phenotype in divergent HIV-1 clades. | J Virol | 2025 | https://conductscience.org/library/papers/40838752 | PubMed |
| 40511646 | Germline-Targeting Strategies to Induce bNAbs against HIV-1. | Curr HIV Res | 2026 | https://conductscience.org/library/papers/40511646 | PubMed |
| 38975023 | Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention. | Microb Cell | 2024 | https://conductscience.org/library/papers/38975023 | PubMed |
| 38628675 | The Question of HIV Vaccine: Why Is a Solution Not Yet Available? | J Immunol Res | 2024 | https://conductscience.org/library/papers/38628675 | PubMed |
| 38412036 | A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope. | J Virol | 2024 | https://conductscience.org/library/papers/38412036 | PubMed |
| 37932288 | Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals. | Nat Commun | 2023 | https://conductscience.org/library/papers/37932288 | PubMed |
| 37852345 | Broadly neutralizing antibodies targeting HIV: Progress and challenges. | Clin Immunol | 2023 | https://conductscience.org/library/papers/37852345 | PubMed |
| 37628824 | Enhancement of Neutralization Responses through Sequential Immunization of Stable Env Trimers Based on Consensus Sequences from Select Time Points by Mimicking Natural Infection. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37628824 | PubMed |
| 37384622 | Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodies. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/37384622 | PubMed |
| 36344847 | Cryo-EM structures of prefusion SIV envelope trimer. | Nat Struct Mol Biol | 2022 | https://conductscience.org/library/papers/36344847 | PubMed |
| 36054228 | Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies. | PLoS Pathog | 2022 | https://conductscience.org/library/papers/36054228 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AICDA | 57379 | PubTator's text mining | https://conductscience.org/library/genes/57379 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| ERVK-20 | 100616444 | PubTator's text mining | https://conductscience.org/library/genes/100616444 | NCBI Gene |
| IGHJ5 | 28476 | PubTator's text mining | https://conductscience.org/library/genes/28476 | NCBI Gene |
| IGHV4-34 | 28395 | PubTator's text mining | https://conductscience.org/library/genes/28395 | NCBI Gene |
| IGKJ1 | 28950 | PubTator's text mining | https://conductscience.org/library/genes/28950 | NCBI Gene |
| IGKV@ | 3519 | PubTator's text mining | https://conductscience.org/library/genes/3519 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
| MGAT1 | 4245 | PubTator's text mining | https://conductscience.org/library/genes/4245 | NCBI Gene |
| SSAV1 | 6739 | PubTator's text mining | https://conductscience.org/library/genes/6739 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27192579
GET https://conductscience.org/api/papers/v1/27192579/authors?page=2